On average per month a patient in Bamako spent $21.24 on diabetes care (assuming 1 blood glucose measurement per month, 8 syringes per month, 1 vial of insulin at an average cost of $10.88 in the public sector, 1 monthly consultation, and travel costs) representing nearly 70% of per capita GDP [12]. This evidence concerns the gene INS and diabetes mellitus.